Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice
{{output}}
The Food and Drug Administration (FDA) recently introduced the Exploratory Investigational New Drug Guidance to expedite the clinical evaluation of new therapeutic and imaging agents. Early clinical studies performed under the auspices of this guidance, so-cal... ...
